IPO Comments on Joint USPTO–FDA Collaboration Initiatives
IPO Comments on Joint USPTO–FDA Collaboration Initiatives
IPO Comments on Joint USPTO–FDA Collaboration Initiatives
IPO Comments Regarding USPTO Initiatives To Ensure the Robustness and [...]
IPO Comments Regarding Expanding Opportunities to Appear Before the Patent [...]
IPO Comments Regarding Expanding Admission Criteria for Registration to Practice [...]
IPO 2023 Special 301 Review Comments
IPO Amicus Brief in Jack Daniel's Properties, Inc. v. VIP [...]
2022 Top 300 Patent Owners
IPO Comments to UKIPO Regarding Transformation Consultation
IPO Amicus Brief in Amgen Inc., et al. v. Sanofi, [...]
IPO Amicus Brief in Abitron Austria Gmbh V. Hetronic International, [...]